McKesson on Thursday reported revenues of $44.1 billion for the first quarter ended June 30, up 37%.
Pfizer on Wednesday announced that it has entered into a definitive agreement to acquire Baxter International’s portfolio of marketed vaccines for $635 million.
GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.
Reckitt Benckiser announced the company will be looking to spin off its pharma business in the next 12 months.
The Food and Drug Administration on Monday expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17.
The Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), a long-acting opioid analgesic.
Onco360, an independent oncology pharmacy and clinical support services company, announced that it has been selected to be part of the highly limited specialty pharmacy network of Zydelig tablets.
The first batch of vaccines for the upcoming flu season is on its way to pharmacies, hospitals and doctors offices.
Innocutis on Monday announced the introduction of Sitavig (acyclovir) 50-mg buccal tablet into North American markets.
Sandoz on Monday announced an agreement with Anacor Pharmaceuticals to obtain exclusive rights to commercialize Kerydin (tavaborole) topical solution, 5%, through its branded dermatology business, PharmaDerm.